Gibson, Dunn & Crutcher advised
Latham & Watkins and Schiff Hardin advised BK Medical on the transaction, which is expected to close in 2022, according to a statement.
BK Medical makes intraoperative imaging and surgical navigation equipment used to guide clinicians during minimally invasive and robotic surgeries. The equipment is also used to visualize deep tissue during procedures in neuro and abdominal surgery, and in ultrasound urology, the statement said.
Headquartered in Boston and Copenhagen, with more than 650 employees, the company BK Medical said it has posted double-digit revenue growth.
GE Healthcare President and CEO Kieran Murphy said the acquisition complements his company’s $3 billion ultrasound business, calling it “another step toward delivering precision health.”
“This transaction helps GE Healthcare continue to expand beyond diagnostics into surgical and therapeutic interventions,” Murphy said.